Enveric Biosciences Inc vs Huntington Ingalls Industries Inc — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Huntington Ingalls Industries Inc trades at $272.7 (market cap $10.95B). The key difference: Huntington Ingalls Industries Inc is far larger — about 2058.3× Enveric Biosciences Inc's market cap, and Huntington Ingalls Industries Inc pays a 1.99% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | HII | |
|---|---|---|
Market Cap | $5.32M | $10.95B |
Sector | Health | Technology |
52-Week High | $17.40 | $453.73 |
52-Week Low | $1.28 | $252.93 |
Enterprise Value | $408.82K | $13.66B |
Dividend Yield | — | 1.99% |
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →